Adicet Bio, Inc.ACETNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
14.71%
↑ 127% above average
Average (39q)
-54.40%
Historical baseline
Range
High:1025.93%
Low:-1808.33%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 14.71% |
| Q2 2025 | -9.68% |
| Q1 2025 | 3.13% |
| Q4 2024 | 5.88% |
| Q3 2024 | -3.03% |
| Q2 2024 | 5.71% |
| Q1 2024 | 49.28% |
| Q4 2023 | 40.52% |
| Q3 2023 | -54.67% |
| Q2 2023 | -8.70% |
| Q1 2023 | -2.99% |
| Q4 2022 | -34.00% |
| Q3 2022 | 10.71% |
| Q2 2022 | -566.67% |
| Q1 2022 | 125.53% |
| Q4 2021 | -6.82% |
| Q3 2021 | -29.41% |
| Q2 2021 | 58.54% |
| Q1 2021 | -78.26% |
| Q4 2020 | 42.50% |
| Q3 2020 | -73.91% |
| Q2 2020 | -91.67% |
| Q1 2020 | 31.43% |
| Q4 2019 | 56.25% |
| Q3 2019 | -471.43% |
| Q2 2019 | 36.36% |
| Q1 2019 | 92.52% |
| Q4 2018 | -764.71% |
| Q3 2018 | 38.18% |
| Q2 2018 | -5.77% |
| Q1 2018 | 77.29% |
| Q4 2017 | -1808.33% |
| Q3 2017 | -112.00% |
| Q2 2017 | 400.00% |
| Q1 2017 | 1025.93% |
| Q4 2016 | -112.71% |
| Q3 2016 | -22.73% |
| Q2 2016 | -46.34% |
| Q1 2016 | 24.24% |
| Q4 2015 | -10.81% |